Selected research
Market Analysis & Forecast
Global Plasma Albumin Market Analysis and Forecast 2026-2032
Market perspective
The global Plasma Albumin market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Plasma Albumin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Plasma Albumin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Plasma Albumin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Plasma Albumin is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global manufacturers of Plasma Albumin include Yuanda Shuyang, Takeda, Weiguang Bio, Tiantan Bio, Shanghai RAAS, Hualan Bio, Shuanglin Bio, Octapharma and LFB Group, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Plasma Albumin, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Plasma Albumin, also provides the sales of main regions and countries. Of the upcoming market potential for Plasma Albumin, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Plasma Albumin sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Plasma Albumin market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Plasma Albumin sales, projected growth trends, production technology, application and end-user industry.
Plasma Albumin Segment by Company
Yuanda Shuyang
Takeda
Weiguang Bio
Tiantan Bio
Shanghai RAAS
Hualan Bio
Shuanglin Bio
Octapharma
LFB Group
Kedrion
Grifols
CSL
CBPO
Boya Bio
Biotest
Plasma Albumin Segment by Type
20-25% Concentrations
5% Concentrations
Plasma Albumin Segment by Application
Therapeutics
Excipient
Other
Plasma Albumin Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Plasma Albumin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Plasma Albumin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Plasma Albumin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Plasma Albumin in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Plasma Albumin manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Plasma Albumin sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 20-25% Concentrations
- 5% Concentrations
Applications
- Therapeutics
- Excipient
- Other
Companies covered
- Yuanda Shuyang
- Takeda
- Weiguang Bio
- Tiantan Bio
- Shanghai RAAS
- Hualan Bio
- Shuanglin Bio
- Octapharma
- LFB Group
- Kedrion
- Grifols
- CSL
- CBPO
- Boya Bio
- Biotest
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Plasma Albumin Market by Type
- 1.2.1 Global Plasma Albumin Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 20-25% Concentrations
- 1.2.3 5% Concentrations
- 1.3 Plasma Albumin Market by Application
- 1.3.1 Global Plasma Albumin Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Therapeutics
- 1.3.3 Excipient
- 1.3.4 Other
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Plasma Albumin Market Dynamics
- 2.1 Plasma Albumin Industry Trends
- 2.2 Plasma Albumin Industry Drivers
- 2.3 Plasma Albumin Industry Opportunities and Challenges
- 2.4 Plasma Albumin Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Plasma Albumin Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Plasma Albumin Revenue by Region
- 3.2.1 Global Plasma Albumin Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Plasma Albumin Revenue by Region (2021-2026)
- 3.2.3 Global Plasma Albumin Revenue by Region (2027-2032)
- 3.2.4 Global Plasma Albumin Revenue Market Share by Region (2021-2032)
- 3.3 Global Plasma Albumin Sales Estimates and Forecasts 2021-2032
- 3.4 Global Plasma Albumin Sales by Region
- 3.4.1 Global Plasma Albumin Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Plasma Albumin Sales by Region (2021-2026)
- 3.4.3 Global Plasma Albumin Sales by Region (2027-2032)
- 3.4.4 Global Plasma Albumin Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Plasma Albumin Revenue by Manufacturers
- 4.1.1 Global Plasma Albumin Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Plasma Albumin Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Plasma Albumin Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Plasma Albumin Sales by Manufacturers
- 4.2.1 Global Plasma Albumin Sales by Manufacturers (2021-2026)
- 4.2.2 Global Plasma Albumin Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Plasma Albumin Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Plasma Albumin Sales Price by Manufacturers (2021-2026)
- 4.4 Global Plasma Albumin Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Plasma Albumin Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Plasma Albumin Manufacturers, Product Type & Application
- 4.7 Global Plasma Albumin Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Plasma Albumin Market CR5 and HHI
- 4.8.2 2025 Plasma Albumin Tier 1, Tier 2, and Tier 3
5 Plasma Albumin Market by Type
- 5.1 Global Plasma Albumin Revenue by Type
- 5.1.1 Global Plasma Albumin Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Plasma Albumin Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Plasma Albumin Revenue Market Share by Type (2021-2032)
- 5.2 Global Plasma Albumin Sales by Type
- 5.2.1 Global Plasma Albumin Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Plasma Albumin Sales by Type (2021-2032) & (K Units)
- 5.2.3 Global Plasma Albumin Sales Market Share by Type (2021-2032)
- 5.3 Global Plasma Albumin Price by Type
6 Plasma Albumin Market by Application
- 6.1 Global Plasma Albumin Revenue by Application
- 6.1.1 Global Plasma Albumin Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Plasma Albumin Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Plasma Albumin Revenue Market Share by Application (2021-2032)
- 6.2 Global Plasma Albumin Sales by Application
- 6.2.1 Global Plasma Albumin Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Plasma Albumin Sales by Application (2021-2032) & (K Units)
- 6.2.3 Global Plasma Albumin Sales Market Share by Application (2021-2032)
- 6.3 Global Plasma Albumin Price by Application
7 Company Profiles
- 7.1 Yuanda Shuyang
- 7.1.1 Yuanda Shuyang Company Information
- 7.1.2 Yuanda Shuyang Business Overview
- 7.1.3 Yuanda Shuyang Plasma Albumin Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 Yuanda Shuyang Plasma Albumin Product Portfolio
- 7.1.5 Yuanda Shuyang Recent Developments
- 7.2 Takeda
- 7.2.1 Takeda Company Information
- 7.2.2 Takeda Business Overview
- 7.2.3 Takeda Plasma Albumin Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 Takeda Plasma Albumin Product Portfolio
- 7.2.5 Takeda Recent Developments
- 7.3 Weiguang Bio
- 7.3.1 Weiguang Bio Company Information
- 7.3.2 Weiguang Bio Business Overview
- 7.3.3 Weiguang Bio Plasma Albumin Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 Weiguang Bio Plasma Albumin Product Portfolio
- 7.3.5 Weiguang Bio Recent Developments
- 7.4 Tiantan Bio
- 7.4.1 Tiantan Bio Company Information
- 7.4.2 Tiantan Bio Business Overview
- 7.4.3 Tiantan Bio Plasma Albumin Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 Tiantan Bio Plasma Albumin Product Portfolio
- 7.4.5 Tiantan Bio Recent Developments
- 7.5 Shanghai RAAS
- 7.5.1 Shanghai RAAS Company Information
- 7.5.2 Shanghai RAAS Business Overview
- 7.5.3 Shanghai RAAS Plasma Albumin Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 Shanghai RAAS Plasma Albumin Product Portfolio
- 7.5.5 Shanghai RAAS Recent Developments
- 7.6 Hualan Bio
- 7.6.1 Hualan Bio Company Information
- 7.6.2 Hualan Bio Business Overview
- 7.6.3 Hualan Bio Plasma Albumin Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.6.4 Hualan Bio Plasma Albumin Product Portfolio
- 7.6.5 Hualan Bio Recent Developments
- 7.7 Shuanglin Bio
- 7.7.1 Shuanglin Bio Company Information
- 7.7.2 Shuanglin Bio Business Overview
- 7.7.3 Shuanglin Bio Plasma Albumin Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.7.4 Shuanglin Bio Plasma Albumin Product Portfolio
- 7.7.5 Shuanglin Bio Recent Developments
- 7.8 Octapharma
- 7.8.1 Octapharma Company Information
- 7.8.2 Octapharma Business Overview
- 7.8.3 Octapharma Plasma Albumin Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.8.4 Octapharma Plasma Albumin Product Portfolio
- 7.8.5 Octapharma Recent Developments
- 7.9 LFB Group
- 7.9.1 LFB Group Company Information
- 7.9.2 LFB Group Business Overview
- 7.9.3 LFB Group Plasma Albumin Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.9.4 LFB Group Plasma Albumin Product Portfolio
- 7.9.5 LFB Group Recent Developments
- 7.10 Kedrion
- 7.10.1 Kedrion Company Information
- 7.10.2 Kedrion Business Overview
- 7.10.3 Kedrion Plasma Albumin Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.10.4 Kedrion Plasma Albumin Product Portfolio
- 7.10.5 Kedrion Recent Developments
- 7.11 Grifols
- 7.11.1 Grifols Company Information
- 7.11.2 Grifols Business Overview
- 7.11.3 Grifols Plasma Albumin Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.11.4 Grifols Plasma Albumin Product Portfolio
- 7.11.5 Grifols Recent Developments
- 7.12 CSL
- 7.12.1 CSL Company Information
- 7.12.2 CSL Business Overview
- 7.12.3 CSL Plasma Albumin Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.12.4 CSL Plasma Albumin Product Portfolio
- 7.12.5 CSL Recent Developments
- 7.13 CBPO
- 7.13.1 CBPO Company Information
- 7.13.2 CBPO Business Overview
- 7.13.3 CBPO Plasma Albumin Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.13.4 CBPO Plasma Albumin Product Portfolio
- 7.13.5 CBPO Recent Developments
- 7.14 Boya Bio
- 7.14.1 Boya Bio Company Information
- 7.14.2 Boya Bio Business Overview
- 7.14.3 Boya Bio Plasma Albumin Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.14.4 Boya Bio Plasma Albumin Product Portfolio
- 7.14.5 Boya Bio Recent Developments
- 7.15 Biotest
- 7.15.1 Biotest Company Information
- 7.15.2 Biotest Business Overview
- 7.15.3 Biotest Plasma Albumin Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.15.4 Biotest Plasma Albumin Product Portfolio
- 7.15.5 Biotest Recent Developments
8 North America
- 8.1 North America Plasma Albumin Market Size by Type
- 8.1.1 North America Plasma Albumin Revenue by Type (2021-2032)
- 8.1.2 North America Plasma Albumin Sales by Type (2021-2032)
- 8.1.3 North America Plasma Albumin Price by Type (2021-2032)
- 8.2 North America Plasma Albumin Market Size by Application
- 8.2.1 North America Plasma Albumin Revenue by Application (2021-2032)
- 8.2.2 North America Plasma Albumin Sales by Application (2021-2032)
- 8.2.3 North America Plasma Albumin Price by Application (2021-2032)
- 8.3 North America Plasma Albumin Market Size by Country
- 8.3.1 North America Plasma Albumin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Plasma Albumin Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Plasma Albumin Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
9 Europe
- 9.1 Europe Plasma Albumin Market Size by Type
- 9.1.1 Europe Plasma Albumin Revenue by Type (2021-2032)
- 9.1.2 Europe Plasma Albumin Sales by Type (2021-2032)
- 9.1.3 Europe Plasma Albumin Price by Type (2021-2032)
- 9.2 Europe Plasma Albumin Market Size by Application
- 9.2.1 Europe Plasma Albumin Revenue by Application (2021-2032)
- 9.2.2 Europe Plasma Albumin Sales by Application (2021-2032)
- 9.2.3 Europe Plasma Albumin Price by Application (2021-2032)
- 9.3 Europe Plasma Albumin Market Size by Country
- 9.3.1 Europe Plasma Albumin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Plasma Albumin Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Plasma Albumin Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Netherlands
10 China
- 10.1 China Plasma Albumin Market Size by Type
- 10.1.1 China Plasma Albumin Revenue by Type (2021-2032)
- 10.1.2 China Plasma Albumin Sales by Type (2021-2032)
- 10.1.3 China Plasma Albumin Price by Type (2021-2032)
- 10.2 China Plasma Albumin Market Size by Application
- 10.2.1 China Plasma Albumin Revenue by Application (2021-2032)
- 10.2.2 China Plasma Albumin Sales by Application (2021-2032)
- 10.2.3 China Plasma Albumin Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Plasma Albumin Market Size by Type
- 11.1.1 Asia Plasma Albumin Revenue by Type (2021-2032)
- 11.1.2 Asia Plasma Albumin Sales by Type (2021-2032)
- 11.1.3 Asia Plasma Albumin Price by Type (2021-2032)
- 11.2 Asia Plasma Albumin Market Size by Application
- 11.2.1 Asia Plasma Albumin Revenue by Application (2021-2032)
- 11.2.2 Asia Plasma Albumin Sales by Application (2021-2032)
- 11.2.3 Asia Plasma Albumin Price by Application (2021-2032)
- 11.3 Asia Plasma Albumin Market Size by Country
- 11.3.1 Asia Plasma Albumin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Plasma Albumin Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Plasma Albumin Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Plasma Albumin Market Size by Type
- 12.1.1 SAMEA Plasma Albumin Revenue by Type (2021-2032)
- 12.1.2 SAMEA Plasma Albumin Sales by Type (2021-2032)
- 12.1.3 SAMEA Plasma Albumin Price by Type (2021-2032)
- 12.2 SAMEA Plasma Albumin Market Size by Application
- 12.2.1 SAMEA Plasma Albumin Revenue by Application (2021-2032)
- 12.2.2 SAMEA Plasma Albumin Sales by Application (2021-2032)
- 12.2.3 SAMEA Plasma Albumin Price by Application (2021-2032)
- 12.3 SAMEA Plasma Albumin Market Size by Country
- 12.3.1 SAMEA Plasma Albumin Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Plasma Albumin Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Plasma Albumin Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Plasma Albumin Value Chain Analysis
- 13.1.1 Plasma Albumin Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Plasma Albumin Production Mode & Process
- 13.2 Plasma Albumin Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Plasma Albumin Distributors
- 13.2.3 Plasma Albumin Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst